Sidoti Csr Cuts Earnings Estimates for SBC Medical Group

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Investment analysts at Sidoti Csr decreased their Q1 2025 earnings estimates for shares of SBC Medical Group in a research note issued to investors on Monday, March 31st. Sidoti Csr analyst A. Shah now anticipates that the company will post earnings per share of $0.15 for the quarter, down from their previous forecast of $0.16. The consensus estimate for SBC Medical Group’s current full-year earnings is $5.02 per share. Sidoti Csr also issued estimates for SBC Medical Group’s Q2 2025 earnings at $0.13 EPS, Q3 2025 earnings at $0.14 EPS, Q4 2025 earnings at $0.11 EPS, FY2025 earnings at $0.54 EPS, Q1 2026 earnings at $0.16 EPS, Q2 2026 earnings at $0.15 EPS, Q3 2026 earnings at $0.15 EPS, Q4 2026 earnings at $0.14 EPS and FY2026 earnings at $0.61 EPS.

SBC Medical Group (NASDAQ:SBC) last announced its quarterly earnings data on Friday, March 28th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.01. The firm had revenue of $57.90 million for the quarter, compared to the consensus estimate of $56.34 million.

SBC Medical Group Trading Down 4.7 %

SBC stock opened at $3.04 on Tuesday. The business’s fifty day moving average price is $4.34. SBC Medical Group has a fifty-two week low of $2.62 and a fifty-two week high of $12.50. The company has a quick ratio of 2.76, a current ratio of 2.79 and a debt-to-equity ratio of 0.06.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.